Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05638854 Org: User:
Start: 12/08/22 End: 07/31/25 Due: 07/31/26

A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05542303 Org: User:
Start: 10/16/22 End: 04/04/23 Due: 04/04/24

A Phase 3 Study of Obexelimab in Patients with IgG4-Related Disease

Phase: N/A Priority: Normal
NCT ID: NCT05662241 Org: User:
Start: 09/30/22 End: 12/31/27 Due: 12/31/28

Study of ZB001 in Chinese Patients With Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT05776121 Org: User:
Start: 05/10/23 End: 04/17/24 Due: 04/17/25

A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)

Phase: N/A Priority: Normal
NCT ID: NCT05786573 Org: User:
Start: 09/25/23 End: 08/31/26 Due: 08/31/27

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06559163 Org: User:
Start: 09/17/24 End: 09/30/26 Due: 09/30/27

A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05794516 Org: User:
Start: 06/19/23 End: 03/21/24 Due: 03/21/25

A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Phase: N/A Priority: Normal
NCT ID: NCT06564311 Org: User:
Start: 08/26/24 End: 02/28/26 Due: 02/28/27